Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-07-12
1993-02-16
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514313, 514314, 514826, 546153, 546155, 546156, 546159, 546162, 546167, 546170, 546171, 546172, 546174, 546176, 546177, A01N 4342, C07D21536
Patent
active
051871807
ABSTRACT:
(Quinolin-2-ylmethoxy)Heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes useful in the treatment of asthma and eye inflamation.
REFERENCES:
patent: 4057559 (1977-11-01), Asselin et al.
patent: 4578398 (1986-03-01), Mobilio et al.
patent: 4775680 (1988-10-01), Gillard et al.
patent: 4783479 (1988-11-01), Mobilio
patent: 4808608 (1989-02-01), Guindon et al.
patent: 4920132 (1990-04-01), Huang et al.
patent: 4929626 (1990-05-01), Mohrs et al.
patent: 4940719 (1990-07-01), Gillard et al.
patent: 4962203 (1990-10-01), Young et al.
patent: 4970215 (1990-11-01), Mohrs et al.
Mobilio et al., J. Med. Chem., 31, 2211-2217 (1988).
Covington Raymond
DiPrima Joseph F.
Ivy C. Warren
Lopez Gabriel
Merck Frosst Canada Inc.
LandOfFree
(Quinolin-2-ylmethoxy)Heterotetrahydrocarbazoles as inhibitors o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (Quinolin-2-ylmethoxy)Heterotetrahydrocarbazoles as inhibitors o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (Quinolin-2-ylmethoxy)Heterotetrahydrocarbazoles as inhibitors o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2148224